Pharmaceutical Profiles the effects of diabetes drug
UK-based Pharmaceutical Profiles has used an imaging technique known as scintigraphy to quantify the effects of Amylin / Eli Lilly’s latest diabetes drug on the stomach.
Archives for September 17, 2008
Aseptic outsources “revolutionary” vial filler
CMO NextPharma has signed a deal to make Aseptic Technologies “revolutionary” ‘closed-vial’ filling system available as part of its offering to clients.
DSM and Caliber team up to develop drug delivery balloon
DSM Biomedical and Caliber Therapeutics aim to expand their presence in the balloon catheter market with a project to develop new drug delivery devices for vascular diseases, including atherosclerosis.
Neose sells PEG tech for $43m
BioGeneriX and Novo Nordisk have signed deals to acquire most of Neose Technologies’ intellectual property for a combined total of $43m.
High-potency unit opens at Phamatek
Pharmatek Laboratories has opened its highly-potent and cytotoxic facility located in San Diego, US, just over a year after announcing its move into this growth area of contract manufacturing.
Exclusive interview with IPEC China chairman Nevin Cheng
IPEC China’s chairman sets out next steps
IPEC China must become a “harmonisation bridge between China and other countries,” according to Colorcon’s Nevin Cheng who was recently elected chairman of the new organisation.
Capsugel targets toxics sector with vibration-free hood
Oral dose filling specialist Capsugel hopes that its new Xcelohood containment system will improve industrial weighing operations during the preparation of high-potency drugs.